Over 80% of CLL with a deletion at 17p13 also present a TP53 mutation in the remaining allele, whereas TP53 mutations in absence of a concomitant deletion at 17p13 occur in 5-10% of CLL cases [5-9]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.